Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:e3-

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jordan, J.
Right arrow Articles by Shannon, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, J.
Right arrow Articles by Shannon, J. R.

(Hypertension. 2000;36:e3.)
© 2000 American Heart Association, Inc.


Hypertension Electronic Pages

Vasopressin and Blood Pressure in Humans

Jens Jordan; Jens Tank

Clinical Research Center, Franz Volhard Klinik, Charite, Humboldt University, Berlin, Germany

Andre Diedrich; David Robertson; John R. Shannon

Nathan Blaser Shy-Drager Research Program, Autonomic Dysfunction Center, Vanderbilt University, Nashville, Tennessee


*    Introduction
 
To the Editor:

The importance of vasopressin for blood pressure regulation in humans has been a matter of debate for the past few decades. In healthy subjects, pharmacological blockade of vascular vasopressin (VI) receptors leads to no or minimal changes in arterial blood pressure.1 This observation suggests that in the presence of intact function of the autonomic nervous system and the renin-angiotensin-aldosterone system, vasopressin release may be of minor importance for the maintenance of blood pressure. However, with impaired autonomic nervous system function or renin-angiotensin-aldosterone system function, vasopressin release may serve as a back-up mechanism to prevent excessive hypotension. For example, the hypotension in vasovagal syncope and pure autonomic failure2 3 and during ganglionic blockade4 5 is associated with a substantial increase in plasma vasopressin concentration. In this study, we applied short hypotensive stimuli during ganglionic blockade to further elucidate the role of vasopressin in blood pressure regulation in humans.

We studied 10 healthy subjects (5 men, 5 women, 33±1.9 years). In all studies, the heart rate was determined by continuous electrocardiogram and the blood pressure was measured by a radial artery catheter. In an initial study, 7 subjects underwent a battery of cardiovascular autonomic reflex tests before and during complete blockade of autonomic ganglia with trimethaphan.5 Before ganglionic blockade, the respiratory sinus arrhythmia ratio was 1.4±0.09. Blood pressure increased 26±4/21±3.7 and 34±1.5/26±2.0 mm Hg with sustained handgrip and cold pressor testing, respectively. Blood pressure did not decrease from baseline during phase 2 of the Valsalva maneuver (40 mm Hg intrathoracic pressure . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Christou, P. Parker Jones, A. E. Pimentel, and D. R. Seals
Increased abdominal-to-peripheral fat distribution contributes to altered autonomic-circulatory control with human aging
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1530 - H1537.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. P. Jones, L. F. Shapiro, G. A. Keisling, J. Jordan, J. R. Shannon, R. A. Quaife, and D. R. Seals
Altered Autonomic Support of Arterial Blood Pressure With Age in Healthy Men
Circulation, November 13, 2001; 104(20): 2424 - 2429.
[Abstract] [Full Text] [PDF]